SEC Filings

SEC Filings

Filing date	Form	Description	View
Mar 05, 2019	10-K	Annual report which provides a comprehensive overview of the company for the past year	View HTML 0001603756-19-000011.pdf 0001603756-19-000011.rtf 0001603756-19-000011.xls EX-101.INS - XBRL INSTANCE DOCUMENT
Mar 05, 2019	3	Initial filing by director officer or owner of more than ten percent.	View HTML 0000899243-19-006281.pdf 0000899243-19-006281.rtf
Mar 05, 2019	4	Statement of changes in beneficial ownership of securities	View HTML 0000899243-19-006285.pdf 0000899243-19-006285.rtf
Feb 13, 2019	SC 13G	A statement of beneficial ownership of common stock by certain persons	View HTML 0000315066-19-000908.pdf 0000315066-19-000908.rtf
Feb 12, 2019	SC 13G	A statement of beneficial ownership of common stock by certain persons	View HTML 0001193125-19-035539.pdf 0001193125-19-035539.rtf 0001193125-19-035539.xls
Feb 11, 2019	SC 13G	A statement of beneficial ownership of common stock by certain persons	View HTML 0001062993-19-000650.pdf 0001062993-19-000650.rtf 0001062993-19-000650.xls
Feb 04, 2019	4	Statement of changes in beneficial ownership of securities	View HTML 0000899243-19-002483.pdf 0000899243-19-002483.rtf
Feb 01, 2019	4	Statement of changes in beneficial ownership of securities	View HTML 0000899243-19-002371.pdf 0000899243-19-002371.rtf
Feb 01, 2019	4	Statement of changes in beneficial ownership of securities	View HTML 0000899243-19-002372.pdf 0000899243-19-002372.rtf
Feb 01, 2019	4	Statement of changes in beneficial ownership of securities	View HTML 0000899243-19-002369.pdf 0000899243-19-002369.rtf

Data provided by Kaleidoscope.

Print Page Email Page Email Alerts RSS Feeds

Questions?

We are here to help answer any questions you may have about the Axonics System and Therapy.

CONTACT US